Cargando…

Genetic polymorphisms analysis of pharmacogenomic VIP variants in Bai ethnic group from China

BACKGROUND: The pharmacogenomics study has been widely used for the study of very important pharmacogenetic (VIP) variants among different ethnic groups. However, there is little known about the pharmacogenomics information regarding Bai family. Our study aimed to screen the polymorphism of the VIP...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Wanlu, Ding, Heng, Cheng, Yujing, Li, Qi, Dai, Run, Yang, Xin, Zhang, Chan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6732286/
https://www.ncbi.nlm.nih.gov/pubmed/31361092
http://dx.doi.org/10.1002/mgg3.884
_version_ 1783449794462613504
author Chen, Wanlu
Ding, Heng
Cheng, Yujing
Li, Qi
Dai, Run
Yang, Xin
Zhang, Chan
author_facet Chen, Wanlu
Ding, Heng
Cheng, Yujing
Li, Qi
Dai, Run
Yang, Xin
Zhang, Chan
author_sort Chen, Wanlu
collection PubMed
description BACKGROUND: The pharmacogenomics study has been widely used for the study of very important pharmacogenetic (VIP) variants among different ethnic groups. However, there is little known about the pharmacogenomics information regarding Bai family. Our study aimed to screen the polymorphism of the VIP gene in Bai nationality. METHODS: We genotyped 81 VIP variants (selected from the PharmGKB database) in the Bai population and then compared them to the other 11 major HapMap populations by chi‐square test, structure and F‐statistics (Fst) analysis. RESULTS: Our results indicated that rs20417 (PTGS2), rs4148323 (UGT1A), and rs1131596 (SLC19A1) were most different in Bai compared with most of the 11 populations from the HapMap data set. Furthermore, population structure and F‐statistics (Fst) analysis also demonstrated that the Bai population has the closest genetic relationship with Han Chinese in Beijing, China (CHB), followed by Japanese in Tokyo, Japan (JPT), and the farthest population from the Yoruba in Ibadan, Nigeria (YRI). CONCLUSIONS: Our study not only presented the genotype frequency difference between the selected population of the Bai population and the other 11 populations, but also showed that the Bai population is most similar to the CHB populations, followed by JPT. These findings would contribute to the development of individualized medicine for the Bai population.
format Online
Article
Text
id pubmed-6732286
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-67322862019-09-12 Genetic polymorphisms analysis of pharmacogenomic VIP variants in Bai ethnic group from China Chen, Wanlu Ding, Heng Cheng, Yujing Li, Qi Dai, Run Yang, Xin Zhang, Chan Mol Genet Genomic Med Original Articles BACKGROUND: The pharmacogenomics study has been widely used for the study of very important pharmacogenetic (VIP) variants among different ethnic groups. However, there is little known about the pharmacogenomics information regarding Bai family. Our study aimed to screen the polymorphism of the VIP gene in Bai nationality. METHODS: We genotyped 81 VIP variants (selected from the PharmGKB database) in the Bai population and then compared them to the other 11 major HapMap populations by chi‐square test, structure and F‐statistics (Fst) analysis. RESULTS: Our results indicated that rs20417 (PTGS2), rs4148323 (UGT1A), and rs1131596 (SLC19A1) were most different in Bai compared with most of the 11 populations from the HapMap data set. Furthermore, population structure and F‐statistics (Fst) analysis also demonstrated that the Bai population has the closest genetic relationship with Han Chinese in Beijing, China (CHB), followed by Japanese in Tokyo, Japan (JPT), and the farthest population from the Yoruba in Ibadan, Nigeria (YRI). CONCLUSIONS: Our study not only presented the genotype frequency difference between the selected population of the Bai population and the other 11 populations, but also showed that the Bai population is most similar to the CHB populations, followed by JPT. These findings would contribute to the development of individualized medicine for the Bai population. John Wiley and Sons Inc. 2019-07-30 /pmc/articles/PMC6732286/ /pubmed/31361092 http://dx.doi.org/10.1002/mgg3.884 Text en © 2019 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Chen, Wanlu
Ding, Heng
Cheng, Yujing
Li, Qi
Dai, Run
Yang, Xin
Zhang, Chan
Genetic polymorphisms analysis of pharmacogenomic VIP variants in Bai ethnic group from China
title Genetic polymorphisms analysis of pharmacogenomic VIP variants in Bai ethnic group from China
title_full Genetic polymorphisms analysis of pharmacogenomic VIP variants in Bai ethnic group from China
title_fullStr Genetic polymorphisms analysis of pharmacogenomic VIP variants in Bai ethnic group from China
title_full_unstemmed Genetic polymorphisms analysis of pharmacogenomic VIP variants in Bai ethnic group from China
title_short Genetic polymorphisms analysis of pharmacogenomic VIP variants in Bai ethnic group from China
title_sort genetic polymorphisms analysis of pharmacogenomic vip variants in bai ethnic group from china
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6732286/
https://www.ncbi.nlm.nih.gov/pubmed/31361092
http://dx.doi.org/10.1002/mgg3.884
work_keys_str_mv AT chenwanlu geneticpolymorphismsanalysisofpharmacogenomicvipvariantsinbaiethnicgroupfromchina
AT dingheng geneticpolymorphismsanalysisofpharmacogenomicvipvariantsinbaiethnicgroupfromchina
AT chengyujing geneticpolymorphismsanalysisofpharmacogenomicvipvariantsinbaiethnicgroupfromchina
AT liqi geneticpolymorphismsanalysisofpharmacogenomicvipvariantsinbaiethnicgroupfromchina
AT dairun geneticpolymorphismsanalysisofpharmacogenomicvipvariantsinbaiethnicgroupfromchina
AT yangxin geneticpolymorphismsanalysisofpharmacogenomicvipvariantsinbaiethnicgroupfromchina
AT zhangchan geneticpolymorphismsanalysisofpharmacogenomicvipvariantsinbaiethnicgroupfromchina